Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma

10.1056/NEJM199108083250603

van Essen-Zandvliet EE, 1992, Am Rev Respir Dis, 146, 547, 10.1164/ajrccm/146.3.547

Global Initiative for Asthma. Global strategy for asthma management and prevention. Washington, D.C.: National Heart, Lung, and Blood Institute, 1995. (Publication no. 95-3659.)

10.1016/0140-6736(90)93098-A

10.1056/NEJM199202203260801

10.1056/NEJM199609193351202

10.1056/NEJM199211123272004

10.1164/ajrccm/144.3_Pt_1.622

10.1016/S0140-6736(94)92996-3

Woolcock A, 1996, Am J Respir Crit Care Med, 153, 1481, 10.1164/ajrccm.153.5.8630590

10.1378/chest.109.4.953

10.1378/chest.108.5.1235

10.1056/NEJM199210223271703

10.1016/0954-6111(94)90042-6

10.1016/0002-9343(94)90045-0

10.1056/NEJM199210223271704

10.1016/0024-3205(93)90730-Q

Cockcroft DW, 1995, Am J Respir Crit Care Med, 152, 1485, 10.1164/ajrccm.152.5.7582281

Yates DH, 1995, Am J Respir Crit Care Med, 152, 1170, 10.1164/ajrccm.152.4.7551366

Lofdahl CG, 1991, Eur Respir J, 4, 1161, 10.1183/09031936.93.04101161

Quanjer PH, 1993, Eur Respir J, 6, 5, 10.1183/09041950.005s1693

Roberts JA, 1992, Am Rev Respir Dis, 145, A418, 10.1164/ajrccm/145.2_Pt_1.418

Gardiner PV, 1994, Am J Respir Crit Care Med, 150, 1006, 10.1164/ajrccm.150.4.7921429

10.1136/thx.50.10.1057

10.1016/S0091-6749(95)70128-1

Whelan CJ, 1993, Br J Pharmacol, 110, 613, 10.1111/j.1476-5381.1993.tb13855.x

10.1164/ajrccm/144.4.788

Advenier C, 1992, Br J Pharmacol, 105, 792, 10.1111/j.1476-5381.1992.tb09059.x

Baluk P, 1994, Am J Physiol, 266, L461

Kallstrom BL, 1994, Br J Pharmacol, 113, 687, 10.1111/j.1476-5381.1994.tb17047.x

Britton MG, 1992, Eur Respir J, 5, 1062, 10.1183/09031936.93.05091062

Kesten S, 1992, Ann Allergy, 69, 415

1997, Am J Respir Crit Care Med, 156, 688, 10.1164/ajrccm.156.3.9611067

10.1183/09031936.94.07101839

Borgstrom L, 1996, Am J Respir Crit Care Med, 153, 1636, 10.1164/ajrccm.153.5.8630614